Matinas BioPharma Holdings, Inc. MTNB
1.14 USD 0.00 (+0.00%)
Nov 4, 2026, 10:36 AM EST
1.07 Day range 1.17
0.966 52-week range 19.95
- YTD
- +94.54%
- 1 year
- -10.24%
Analyst view
Price target (mean) —
Ratings (0m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.78 | -0.78 – -0.78 | -1.50 | +48.0% | 0 | 0.0% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | -1.50 | 0.0% | 0 | 0.0% | 0 |
| Current year | -4.06 | -4.06 – -4.06 | -5.50 | +26.2% | 0 | -100.0% | 1 |
| Next year | -3.00 | -4.50 – -1.50 | -4.06 | +26.1% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 31, 2024 | Maxim Group | Downgrade | Buy | Hold |
| Jan 31, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Aug 13, 2020 | Aegis Capital | Maintained | — | Buy |
| Jan 27, 2020 | Piper Sandler | Initiated | — | Overweight |
| Jan 24, 2020 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| Jun 26, 2019 | HC Wainwright & Co. | Initiated | — | Buy |
| May 17, 2019 | BTIG | Initiated | — | Buy |
| Feb 11, 2019 | Roth Capital | Initiated | — | Buy |
| Nov 13, 2018 | Maxim Group | Maintained | Buy | Buy |
| Aug 13, 2018 | Maxim Group | Maintained | Buy | Buy |
| Jul 10, 2018 | Maxim Group | Maintained | Buy | Buy |